Publiziert in: Marktpuls, Unternehmen
Frei

Invitation to Roche Analyst Event on Diagnostics Division at AACC 2022 Montag, 27. Juni 2022 - 14:08

Investor Update  ?v=11232021124200
Invitation to Roche Analyst Event on Diagnostics Division at AACC 2022
 

ee1027ae-9029-4900-b054-3076486e8f78

 

We are pleased to invite you to an analyst event on Tuesday, 26 July 2022, to discuss Roche's Diagnostics Division, in conjunction with the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Exposition in Chicago, Illinois (July 24-28, 2022).


AACC brings together the global leaders in clinical chemistry, molecular diagnostics and lab management, and is the largest dedicated exhibition of equipment, instruments and services for clinical laboratories in the world.

The Analyst Event will start with a presentation on the Diagnostics Division and on AACC highlights followed by a Q&A session.

Key management from the Diagnostics division will be present:
Thomas Schinecker, CEO Roche Diagnostics
Ann Costello, Global Head Roche Diagnostics Solutions
Cindy Perettie, Head of Molecular Labs
Matt Sause, President and CEO Roche Diagnostics, North America
Palani Kumaresan, Global Head of R&D Roche Diagnostics Solutions

Meeting information:
Date/Time (CDT):
Tuesday, 26th July 2022
5:30pm Registration desk opens
6:00pm Start of meeting
7:15pm End of meeting followed by a buffet reception

Venue:
Palmer House Hilton Hotel
Meeting room: Crystal Ballroom (Level 3)
17 East Monroe Street
60603 Chicago, Illinois
> map

To register for the on site event, please follow this link (Password: Analyst2022).*
Covid-19 rapid antigen tests and masks will be available at the registration desk for those who would like to use them.

Participants who cannot join the event on site may dial in to the live webinar (live access to the speakers) and are kindly asked to pre-register here.*

6:00 - 7:15 pm CDT / 7:00 - 8:15 pm EDT / 4:00 - 5:15 pm PDT

Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com.

The presentation slides will be available for download from the IR website at 5:00pm CDT on the day of the event. > click here.

A replay of the live webinar will be available via > ir.roche.com

*privacy notice

 

Best regards,

 

Bruno Eschli
Head of Investor Relations

 

Birgit Masjost
Investor Relations Officer

 

 


 

Roche Investor Relations

 

Dr. Bruno Eschli

Phone: +41 61 68-75284

e-mail: bruno.eschli@roche.com

 

Dr. Sabine Borngräber

Phone: +41 61 68-88027

e-mail: sabine.borngraeber@roche.com

 

Dr. Birgit Masjost

Phone: +41 61 68-84814

e-mail: birgit.masjost@roche.com

 

Dr. Gerard Tobin

Phone: +41 61 68-72942

e-mail: gerard.tobin@roche.com

 

 

Investor Relations North America

 

Loren Kalm

Phone: +1 650 225 3217

e-mail: kalm.loren@gene.com

 

 

 

 

 

All rights reserved ©2022 F. Hoffmann-La Roche Ltd.
Group Communications, Grenzacherstrasse 124, CH-4070 Basel, Switzerland